The Use of Novel Oral Anticoagulants in Atrial Fibrillation

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 15, Iss. 2, 2015-08 ,pp. : 97-100

Bentham Science Publishers

Access to resources Recommend Favorite

Association of Warfarin Use With CHADS₂ Score in 441 Patients With Nonvalvular Atrial Fibrillation and No Contraindications to Warfarin

By Desai Harit V.   Aronow Wilbert S.   Gandhi Kaushang   Bakerywala Suhalia   Laimuanpuii Judy   Sharma Mala   Peterson Stephen J.  

Preventive Cardiology, Vol. 13, Iss. 4, 2010-0 ,pp. : 172-174

Blackwell Publishing

Access to resources Recommend Favorite

Biomarker Assays for Personalised Stroke Risk Assessment in Atrial Fibrillation

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 17, Iss. 1, 2017-07 ,pp. : 58-63

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation and Management of Atrial Fibrillation

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 233-244

Bentham Science Publishers

Access to resources Recommend Favorite

Regulated endothelial cell expression of novel anticoagulants: a strategy for the prevention and therapy of intravascular thrombosis

By Dorling A.   Chen D.   Riesbeck K.   McVey J.   Kemball-Cook G.   Tuddenham E.G.   Lechler R.I.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 971-971

Elsevier

Access to resources Recommend Favorite